Delivery Order SPE2DB20D3303-SPE2DB25FA0QY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,102.40 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packaging) on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at...
- The Defense Logistics Agency awarded a $2,386.52 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on May 20, 2025, with an ultimate completion date of May 21, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,039.86 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for Lo Loestrin Fe 1-10 tablets (quantity: 28-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 3, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,398.34 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count package) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a supply of a brand-name oral contraceptive medication. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,793.99 firm fixed-price delivery order for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,942.24 to AmerisourceBergen Drug Corp for the supply of Lo Loestrin FE 1-10 tablets (28-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of September 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds a significant indefinite delivery contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,042.64 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. The order...
- The Defense Logistics Agency awarded a delivery order valued at $4,455.71 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $37,032.75 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablet 28-count units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,560.38 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA0QYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,420.05 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation, executed on June 24, 2025, with an ultimate completion date of June 25, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As the prime contractor on the comprehensive DLA pharmaceutical IDC, the company supplies a wide range of medications and medical supplies across multiple therapeutic domains to support Defense Health Agency and broader Department of Defense healthcare requirements. This specific delivery order for Lo Loestrin Fe, a hormone-based contraceptive medication, exemplifies the company's role in providing diverse pharmaceutical commodities to support military medical readiness and personnel healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/24/25 |